ArticleThe protein journal2009
Using support vector machine combined with post-processing procedure to improve prediction of interface residues in transient complexes.
Article in The protein journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reliable prediction of interface residues in transient complexes remains challenging, yet is highly desirable for the design of new drugs. The existing computational methods mainly rely on evolutionary information to identify these key residues, but evolutionary information may not be effective for the interface residues in all types of transient complexes, such as antigen-antibody complexes. Herein we combined B-factor with sequence profile and accessible surface area to predict these important residues using support vector machine (SVM). Furthermore, a post-processing method was developed to reduce the number of false positives recognized by SVM. The prediction results show that B-factor is an effective indicator for the interface residues in antigen-antibody complexes as well as those in other types of transient complexes. In addition, we found that the post-processing procedure made an important contribution to further improve the prediction performance. Consequently, the proposed approach could provide new insight into accurately predicting interface residues in different types of transient complexes.
Indexed as
Identifiers
19760494What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.